Passio Biomaterials sp. z o.o.

Research and experimental development on biotechnology

KRS: NIP: REGON:

Overview

Status
Active
Registry date
2016-12-01
Share capital
1,250,000.00 PLN
Registered address
ul. Wojska Polskiego 65A/215, 85-825 Bydgoszcz, Poland
Website
Email

Financials

Only balance sheet data (assets and liabilities) is available. The income statement (P&L) is not available in the source filing for this period.

Revenue history (in k)

Filing timeliness

2 of 6 financial statements were filed late (the longest delay 174 days for 2022).

  • 202514/07/2026
  • 202415/07/2025
  • 202312/07/2024
  • 202205/01/2024
  • 202129/11/2022
  • 202014/10/2021
Filed on timeDelayFiling deadline

Data and insights are generated automatically from financial statements – they may contain errors and are neither a credit assessment nor business advice.

Authorized Representatives

Emil Łukasz Klucz age 47 – President of the Management Board
Katarzyna Klucz age 41 – Attorney-in-fact (sole)

Manner of representation

In the case of a one-person management board, the member of the management board makes declarations on behalf of the company. In the case of a management board consisting of two or more persons, joint action by two members of the management board or by one member of the management board jointly with a commercial proxy is required to make declarations on behalf of the company.

Ownership

OwnerSharesShare valueStake
2,500$67,531.0620%
9,428$254,673.1575.424%
Others
572$15,451.114.576%

Beneficial owners

Person

Bank accounts

Was a VAT taxpayer from 2017-03-31 to 2024-10-28.

Reason for removal: Art. 96 ust. 9a pkt 3 (VAT returns showing no transactions filed for 6 consecutive months or 2 quarters)

Debt

2 closed proceedings recorded in KRZ history.

Registration dateProceeding typeStatus
Jan 19, 2026
Discontinued enforcement proceedings
Closed
Dec 29, 2025
Discontinued enforcement proceedings
Closed

Public aid

5 public aid cases recorded, with a total value of $4,596.

PurposeGross amount
Aid compensating for the negative economic consequences of COVID-19, granted in limited amounts
$1,282
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$112
De minimis aid (in accordance with Commission Regulation No 1407/2013 or earlier)
$61

Competitors

Change history

DateEvent
2022-12-29Address change
2019-02-28Share capital increase
2019-02-28PKD change
2018-04-23Share capital increase
2018-03-06Share capital increase

FAQ

Last updated: 2026-07-15